United States · 
Who invested in Escient Pharmaceuticals?
Escient Pharmaceuticals's investors include New Enterprise Associates, Perceptive Advisors, 5AM Ventures, Redmile Group and Sanofi.
United States · Series C startup
Who invested in Escient Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$120Mraised across 1 round since 2022, from 1 source
- Latest round
- Series C, $120MNov 2022
- Investors
- 5
The rounds
- Nov 2022Series C$120M
Source recordedSEC filing: $60M sold, first sale Nov 2022
Founders and team
From the SEC filings it signed: 3 on the team.
- Aaron Sereda MishelExecutive Officeri
- Joshua GrassExecutive Officer, Directori
- Marcus BoehmExecutive Officeri
On the board, as filediAndrew Sereda SchwabCharles Sereda ZukerJason Sereda HaflerJeenJoo Sereda KangKathleen Sereda GlaubKevin Sereda RaidyPeter Sereda Hirth
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Escient Pharmaceuticals
How much has Escient Pharmaceuticals raised?
Escient Pharmaceuticals has raised $120M across 1 round since 2022.
When did Escient Pharmaceuticals last raise?
Escient Pharmaceuticals's most recent round was a Series C of $120M in Nov 2022.
What was Escient Pharmaceuticals's biggest round?
Its most recent round, $120M in Nov 2022, is also its largest on record.
Who backed Escient Pharmaceuticals first?
Escient Pharmaceuticals's first round on record, in Nov 2022, was backed by New Enterprise Associates, Perceptive Advisors and 5AM Ventures and 2 others.
What stage is Escient Pharmaceuticals at?
Escient Pharmaceuticals's latest named round is a Series C, in Nov 2022.
Where is Escient Pharmaceuticals based?
Escient Pharmaceuticals is based in the United States.
Companies like Escient Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.